Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2021

Nov 15, 2021

SELL
$3.43 - $5.63 $285,345 - $468,365
-83,191 Closed
0 $0
Q1 2021

May 14, 2021

BUY
$4.73 - $8.15 $391,227 - $674,102
82,712 Added 17267.64%
83,191 $424,000
Q4 2020

Feb 08, 2021

BUY
$4.92 - $30.67 $885 - $5,520
180 Added 60.2%
479 $2,000
Q3 2020

Nov 13, 2020

BUY
$21.66 - $38.86 $6,476 - $11,619
299 New
299 $7,000

Others Institutions Holding APRE

About Aprea Therapeutics, Inc.


  • Ticker APRE
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Description
  • Aprea Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on developing and commercializing novel cancer therapeutics that target DNA damage response pathways. Its lead product candidate is ATRN-119, an oral ATR inhibitor that is in phase 1/2a clinical trial to treat patients with advanced solid tumors. The company's products...
More about APRE
Track This Portfolio

Track Fil LTD Portfolio

Follow Fil LTD and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Fil LTD, based on Form 13F filings with the SEC.

News

Stay updated on Fil LTD with notifications on news.